Wyoming was one of the first states to enact a law to allow out-of-state regulated insurers to sell insurance products domestically, in an attempt to increase competition and decrease the cost of entering the new market. Although Wyoming has made limited strides in health care cost transparency, the Wyoming Hospital Association has attempted to fill in the gap by offering a price disclosure database for its hospitals online. A coalition of Wyoming employers is also interested in obtaining charge data across all insured in order to better negotiate rates directly with providers.
In the 2019 legislative session, the Wyoming legislature introduced several legislation designed to address rising prescription drug prices, including drug importation (HB 287) and the Wyoming Health Care Pricing Transparency Act (HB 292), which requires insurers to provide health claims data to group purchasers of private health benefit plans. While neither of these measures passed, the state did enact HB 63, joining other states to prohibit PBMs from penalizing the disclosure of prescription cost information or affordable alternatives.
The State Database
The Source tracks state activities impacting healthcare price and competition in both legislation and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare. We currently cover bills from 2017-2019 and key statutes from each state. Search the database for specific bills, statutes or cases by using keyword, key issue category, and/or jurisdiction.
*Note: 2019 legislative session updates are currently in progress. Check back weekly for updates.